Study guide
2.4 Medication Effects, Polypharmacy & Occupational Performance
NBCOT COTA Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & NBCOT COTA Exam Overview
1.1 About the NBCOT COTA Examination & 2026 Logistics 1.2 OTPF-4 Foundations & Professional Terminology 1.3 COTA Scope of Practice & OTR Supervision Models
2 Chapter 2: Client Information Gathering & Occupational Profile
2.1 Building the Occupational Profile & Interviewing Techniques 2.2 Chart Review, Interprofessional Collaboration & Precautions 2.3 Cultural Competence, Health Literacy & Family Systems 2.4 Medication Effects, Polypharmacy & Occupational Performance
3 Chapter 3: Clinical Assessment Methods & Data Collection
3.1 Standardized & Non-Standardized Assessment Administration 3.2 Screening Body Functions & Motor Performance 3.3 Sensory, Perceptual & Cognitive Screening 3.4 Observational Assessment in Natural Contexts 3.5 Monitoring the Intervention Plan, Outcomes & Care Transitions
4 Chapter 4: Lifespan Development & Performance Factors
4.1 Pediatric Developmental Milestones & Reflexes 4.2 Adolescent Development, Identity & Transition Services 4.3 Adult Aging, Sensory Decline & Physical Changes 4.4 Developmental & Occupational Performance Theories
5 Chapter 5: Activities of Daily Living (ADLs) & Self-Care Training
5.1 Feeding, Eating & Swallowing Interventions 5.2 Upper & Lower Body Dressing, Hygiene & Grooming 5.3 Bathing, Toileting & Tub Transfers 5.4 Bed Mobility, Wheelchair Transfers & Functional Mobility
6 Chapter 6: Instrumental Activities of Daily Living (IADLs) & Community Participation
6.1 Home Management & Meal Preparation 6.2 Medication Management, Health Management & Financial Tasks 6.3 Community Mobility, Driving Rehabilitation & Leisure
7 Chapter 7: Therapeutic Exercises, Activities & Motor Rehabilitation
7.1 Biomechanical Approaches: ROM, Strengthening & Endurance 7.2 Motor Learning Principles & Neurodevelopmental Approaches 7.3 Task-Oriented Training, CIMT & Bilateral Integration 7.4 Physical Agent Modalities (PAMs) in OT Practice 7.5 Preparing the Intervention Environment: Lines, Equipment & Telehealth
8 Chapter 8: Pediatric Conditions & Intervention Strategies
8.1 Cerebral Palsy, Down Syndrome & Spina Bifida 8.2 Autism Spectrum, ADHD & Sensory Processing Differences 8.3 Developmental Coordination Disorder & Fine/Visual Motor Deficits 8.4 School-Based OT Practice & Early Intervention (IDEA)
9 Chapter 9: Adult Physical Rehabilitation & Neurological Conditions
9.1 Stroke (CVA) & Traumatic Brain Injury (TBI) 9.2 Progressive Neurodegenerative Diseases (PD, MS, ALS) 9.3 Spinal Cord Injury Rehabilitation (C1-T12+) 9.4 Orthopedic Conditions, Fractures & Joint Replacements
10 Chapter 10: Hand Therapy, Upper Extremity Rehabilitation & Orthotics
10.1 Tendon Repairs & Peripheral Nerve Injuries 10.2 Cumulative Trauma & Upper Extremity Overuse 10.3 Orthosis Fabrication Principles, Types & Precautions 10.4 Edema Management, Scar Care & Wound Healing 10.5 Amputation, Prosthetic Devices & Prosthetic Training
11 Chapter 11: Cognitive, Perceptual & Mental Health Interventions
11.1 Cognitive Rehabilitation: Memory, Attention & Executive Function 11.2 Dementia & Neurocognitive Disorder Management 11.3 Psychosocial & Mental Health Conditions 11.4 Coping Mechanisms, Stress Management & Emotional Regulation 11.5 Sleep, Rest, Substance Use & Wellness Promotion
12 Chapter 12: Assistive Technology, Seating & Environmental Modifications
12.1 Wheelchair Mobility, Seating & Positioning 12.2 Assistive Technology, AAC & Electronic Aids (EADLs) 12.3 Environmental Accessibility, Home Modifications & ADA Standards
13 Chapter 13: Group Dynamics, Therapeutic Media & Caregiver Training
13.1 Group Dynamics & Mosey's Developmental Groups 13.2 Therapeutic Media, Crafts & Activity Analysis 13.3 Caregiver Education, Training & Health Literacy
14 Chapter 14: Safety, Infection Control & Clinical Precautions
14.1 Infection Control, Standard & Transmission-Based Precautions 14.2 Clinical Precautions & Medical Emergency Protocols 14.3 Fall Prevention, Environmental Hazards & Incident Reporting 14.4 Preventing Professional Burnout: Practitioner Self-Care & Workload Advocacy
15 Chapter 15: Clinical Documentation, Reimbursement & Service Management
15.1 SOAP Notes, Goal Writing & Medical Necessity 15.2 Healthcare Reimbursement: Medicare, Medicaid & Managed Care 15.3 Quality Improvement, Program Evaluation & Inventory Management
16 Chapter 16: Professional Ethics, Evidence-Based Practice & Competency
16.1 AOTA Code of Ethics: Principles & Moral Decision-Making 16.2 Evidence-Based Practice, Research Literacy & Scholarship 16.3 Continuing Competency, Professional Development & Mentorship 16.4 Population Health Programming, Aging in Place & Social Determinants 16.5 NBCOT Practice Standards & the Candidate/Certificant Code of Conduct
2.4 Medication Effects, Polypharmacy & Occupational Performance
Key Takeaways Explain This Topic AI
COTAs never prescribe, adjust, administer, or withhold medication; the COTA's blueprint responsibility is to recognize how a client's medications alter occupational performance, adapt the session, and report observations to the supervising OTR and nursing.
Polypharmacy is conventionally defined as the concurrent use of five or more medications, and the AGS Beers Criteria (2023 update) is the reference list of potentially inappropriate medications in adults 65 and older.
Anticholinergic burden produces a recognizable functional cluster — dry mouth, blurred near vision, constipation, urinary retention, confusion, and impaired heat tolerance — that directly degrades reading, feeding, toileting, and community participation.
Beta-blockers blunt the heart-rate response to exertion, so activity intensity must be graded with a rating of perceived exertion scale rather than a target heart rate.
Session timing is a legitimate clinical intervention: schedule therapy at the analgesic peak, during a Parkinson's client's medication 'on' period, and away from the sedation window that follows a benzodiazepine or opioid dose.
Last updated: August 2026
Medication Effects, Polypharmacy & Occupational Performance
The COTA blueprint lists medication side effects and interactions among the internal and external factors that influence a client's engagement in occupation. That single line carries real weight: on any given caseload, the reason a client suddenly cannot complete a morning ADL routine is at least as likely to be pharmacological as it is musculoskeletal.
Be clear about the boundary before anything else. A COTA does not prescribe, adjust doses, administer, withhold, or counsel on the pharmacology of a medication. What the COTA does is recognize a functional change, connect it to a plausible medication-related cause, adapt the activity to keep the client safe, document objectively, and report to the supervising OTR and the nurse. On the exam, any option in which the COTA changes a medication, tells the client to skip a dose, or interprets a drug level is wrong on its face.
1. Polypharmacy & the AGS Beers Criteria
Polypharmacy is conventionally defined as the concurrent use of five or more medications . Each additional agent multiplies the chance of an interaction, and older adults are more sensitive to many drugs because of altered metabolism, reduced renal clearance, and changed body composition.
The American Geriatrics Society (AGS) Beers Criteria , most recently updated in 2023 , is the standard explicit list of potentially inappropriate medications (PIMs) for adults aged 65 and older. It is organized into tables covering medications to avoid in most older adults, medications to avoid with specific conditions, medications to use with caution, clinically important drug–drug interactions, renal dosing, and — critically for occupational therapy — a dedicated table of drugs with strong anticholinergic properties . The 2023 update specifically strengthened the warnings about cumulative anticholinergic burden and about combining three or more CNS-active drugs .
PIM use is associated with falls, cognitive decline, frailty, hospitalization, and mortality — the exact outcomes occupational therapy is trying to prevent.
Note
The COTA does not perform a medication reconciliation and does not decide whether a drug is appropriate. Knowing that Beers-listed agents are a red flag lets the COTA raise the right question with the OTR and the nurse: "This client is on three sedating medications and just failed a transfer she passed yesterday — should the team review this?"
2. Drug Classes Mapped to Occupational Consequences
Drug Class Common Functional Effect COTA Adaptation
Antihypertensives, diuretics, alpha-blockers Orthostatic hypotension, dizziness on rising; diuretics add urinary urgency and frequency Change position in stages with a seated pause; check blood pressure before standing ADLs; schedule toileting proactively and avoid scheduling a session at the peak diuretic window
Benzodiazepines, "Z-drugs," sedative-hypnotics Sedation, slowed reaction time, impaired new learning, markedly increased fall risk (Beers-listed) Avoid the 1–2 hours after dosing for high-demand mobility; reduce cognitive load; use errorless teaching; strict fall precautions
Opioid analgesics Sedation, nausea, constipation, delirium risk; but also a window of improved tolerance for movement Schedule demanding ROM or transfer work at the analgesic peak ; screen for over-sedation before mobilizing; expect bowel-routine impact on toileting goals
Anticoagulants and antiplatelets (warfarin, DOACs) Easy bruising, hematoma, prolonged bleeding from minor skin trauma Avoid aggressive resistive work, forceful manual techniques, and high-fall-risk tasks when the INR is supratherapeutic; pad splints and equipment edges; inspect skin
Antipsychotics Extrapyramidal effects — parkinsonian rigidity, akathisia, tardive dyskinesia — plus sedation and orthostasis Report new tremor, restlessness, or involuntary orofacial movement immediately; adapt for reduced dexterity; expect impact on feeding and handwriting
Carbidopa–levodopa (Parkinson's disease) "On/off" fluctuations, end-of-dose wearing off, peak-dose dyskinesia Book the session during the "on" period (commonly beginning roughly 45–60 minutes after a dose); document performance in both states so the OTR and physician can see the pattern
Corticosteroids Skin fragility and easy tearing, proximal muscle weakness, hyperglycemia, long-term bone loss Use gentle handling and padded straps; monitor for proximal weakness in sit-to-stand; fall precautions for bone fragility
Beta-blockers Blunted heart-rate rise with exertion, so heart rate under-reports true workload Grade intensity with a rating of perceived exertion (RPE) scale and symptom monitoring rather than a target heart rate
Chemotherapeutic agents Cancer-related fatigue, chemotherapy-induced peripheral neuropathy, neutropenia, nausea Energy conservation and pacing; protective sensation training and thermal safety; follow neutropenic precautions
Anticholinergic agents (many antihistamines, bladder antispasmodics, tricyclics, some antipsychotics) The classic cluster: dry mouth, blurred near vision, constipation, urinary retention, confusion, impaired sweating and heat tolerance Enlarge print and increase task lighting; ensure hydration and oral care; watch for delirium; avoid hot environments and monitor for overheating
The Anticholinergic Cluster Is an ADL Problem, Not Just a Symptom List
Take a single client on a bladder antispasmodic plus a sedating antihistamine plus a tricyclic. The blurred near vision blocks reading a medication label or a recipe. Dry mouth impairs bolus formation and makes swallowing thicker textures harder. Constipation disrupts the bowel program that the toileting goal depends on. Confusion undermines every new compensatory strategy taught that week. Impaired sweating makes an outdoor community-mobility session genuinely dangerous in summer heat. One pharmacological mechanism, five broken occupations.
- 3. Timing, Grading & Objective Reporting
- Session Timing as an Intervention
Pain medication: schedule ROM, wound care tolerance, and transfer training at the analgesic peak, not at the end of the dosing interval.
Parkinson's medication: work in the "on" window for motor tasks; use the "off" window deliberately only when the goal is to teach compensatory strategies for the client's worst-case state.
Sedatives and hypnotics: avoid the hours immediately after dosing for anything requiring balance or new learning.
Diuretics: anticipate the urgency window and either build toileting into the session or reschedule.
Insulin and oral hypoglycemics: know when the client last ate and last dosed before a physically demanding session, and recognize hypoglycemia (shakiness, diaphoresis, confusion).
What to Document and Report
Objective, observable, quantified — never a diagnosis:
✅ "Client required 3 seated rest breaks and reported dizziness on 2 of 3 sit-to-stand attempts today; BP 96/58 seated after standing trial. Session limited to seated grooming. Nursing and supervising OTR notified."
- ❌ "Client's blood pressure medication is too strong and should be lowered."
- The Client-Education Line
Medication management is a genuine occupation — it sits under Health Management in the OTPF-4 — so the COTA absolutely may train a client in the performance of the routine: organizing a pill box, reading and enlarging labels, setting alarms, opening containers with arthritic hands, building the habit into an existing morning routine, and using an automated dispenser. What the COTA may not do is teach what a drug does pharmacologically, what dose to take, or whether to continue it. That content belongs to the prescriber and pharmacist.